成人男性猴痘病例与疫苗接种的种族和民族差异——美国,2022年5月至12月
截至2022年12月31日,美国报告猴痘病例29939例,93.3%发生于成人男性。研究计算发病率比和疫苗接种率比,发现非西班牙裔黑人和西班牙裔男性发病率高于白人男性,且疫苗接种与病例数比值低于白人男性,提示接种需求未满足。
要点
- 2022年8月疫情高峰时,黑人男性猴痘发病率比白人男性高(RR=6.9),西班牙裔男性为RR=4.1。
- 全程分析期间,黑人男性疫苗接种与病例数比值为8.8,西班牙裔为16.2,均低于白人男性的42.5。
- 黑人、西班牙裔男性疫苗接种率相对不足,需持续实施基于公平的疫苗接种策略。
核心结论
- 黑人、西班牙裔男性猴痘疫苗接种率与病例数比值低于白人男性,接种需求未满足。
- 增加疫苗接种的努力仅部分成功减少总体发病率差异。
- 需继续实施基于公平的疫苗接种策略以提高所有种族和民族群体的接种率并降低猴痘发病率。
研究设计与样本
- 分析美国2022年5月10日至12月31日成人男性(≥18岁)猴痘监测和疫苗接种数据。
- 计算发病率比、疫苗接种率比和疫苗接种与病例数比值,并评估趋势。
主要发现
- 截至2022年12月31日,美国报告猴痘病例29939例,93.3%发生于成人男性。
- 2022年5月10日至12月31日,723112人接种首剂JYNNEOS疫苗,89.7%为男性。
- 2022年8月疫情高峰时,黑人男性发病率比白人男性高(RR=6.9),西班牙裔男性为RR=4.1。
- 全程分析期间,黑人男性疫苗接种与病例数比值为8.8,西班牙裔为16.2,白人男性为42.5。
关键数值与推荐
- 2022年8月高峰时发病率比:黑人男性RR=6.9,西班牙裔男性RR=4.1(均较白人男性高)。
- 全程疫苗接种与病例数比值:黑人男性8.8,西班牙裔男性16.2,白人男性42.5。
临床怎么用
- 原文未据此给出临床推荐。
- 作者认为需继续实施基于公平的疫苗接种策略以提高接种率并减少发病率差异。
- 近期模型数据显示,基于当前接种覆盖率,许多美国辖区易出现猴痘疫情复燃,强调继续接种的必要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
As of December 31, 2022, a total of 29,939 monkeypox (mpox) cases* had been reported in the United States, 93.3% of which occurred in adult males. During May 10-December 31, 2022, 723,112 persons in the United States received the first dose in a 2-dose mpox (JYNNEOS)† vaccination series; 89.7% of these doses were administered to males (1). The current mpox outbreak has disproportionately affected gay, bisexual, and other men who have sex with men (MSM) and racial and ethnic minority groups (1,2). To examine racial and ethnic disparities in mpox incidence and vaccination rates, rate ratios (RRs) for incidence and vaccination rates and vaccination-to-case ratios were calculated, and trends in these measures were assessed among males aged ≥18 years (males) (3). Incidence in males in all racial and ethnic minority groups except non-Hispanic Asian (Asian) males was higher than that among non-Hispanic White (White) males. At the peak of the outbreak in August 2022, incidences among non-Hispanic Black or African American (Black) and Hispanic or Latino (Hispanic) males were higher than incidence among White males (RR = 6.9 and 4.1, respectively). Overall, vaccination rates were higher among males in racial and ethnic minority groups than among White males. However, the vaccination-to-case ratio was lower among Black (8.8) and Hispanic (16.2) males than among White males (42.5) during the full analytic period, indicating that vaccination rates among Black and Hispanic males were not proportionate to the elevated incidence rates (i.e., these groups had a higher unmet vaccination need). Efforts to increase vaccination among Black and Hispanic males might have resulted in the observed relative increased rates of vaccination; however, these increases were only partially successful in reducing overall incidence disparities. Continued implementation of equity-based vaccination strategies is needed to further increase vaccination rates and reduce the incidence of mpox among all racial and ethnic groups. Recent modeling data (4) showing that, based on current vaccination coverage levels, many U.S. jurisdictions are vulnerable to resurgent mpox outbreaks, underscore the need for continued vaccination efforts, particularly among racial and ethnic minority groups.
引用
- Kota KK, Hong J, Zelaya C, et al. Racial and Ethnic Disparities in Mpox Cases and Vaccination Among Adult Males - United States, May-December 2022. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37053122. doi:10.15585/mmwr.mm7215a4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。